To view more news and media here in our Newsroom

Click Here

Tomorrow’s Cancer Treatments Today: Precision Medicine Intersects with Immunotherapy to Shrink Advanced Cancer in Maryland Woman

(Washington, D.C.)  – A Maryland woman is benefitting from the intersection of two emerging fields of science: precision medicine to genetically profile cancer and immunotherapy to unleash the immune system to fight it. It’s a case her doctors are calling “remarkable.” Diane Lucey, 49 of Leonardtown, Maryland was living in Georgia in 2014 when she noticed a small bump in her mouth.  The two centimeter tumor was determined to be a rare type of cancer called neuroendocrine carcinoma. She had it surgically removed, received six weeks of radiation and thought she was cancer free. But in the summer of 2016…

Read More

Healthy Heart Advice for Women

 "Goldilocks" Exercise and SleepExercise and good rest are healthy habits, right?  What is the right amount for optimal cardiovascular health? For exercise, brisk walking is good enough - 30 to 60 minutes on most days of the week does the trick!  Women who exercise moderately and regularly experience fewer than half as many heart attacks as those who don’t. And, research in healthy women shows that the optimal sleep duration is seven hours.  Less than seven hours is associated with increased heart risk.  Now here’s the interesting part:  you can get too much of a “good thing.”  Exercise and sleep…

Read More

Georgetown Clinical Trial Testing Nilotinib in Alzheimer’s Disease Begins

WASHINGTON (January 24, 2017) – A clinical trial to examine the effect of nilotinib on clinical outcomes and biomarkers in people with mild to moderate Alzheimer’s disease has opened at Georgetown University Medical Center (GUMC).The clinical trial is a phase II, randomized, double blinded, placebo-controlled study to evaluate the impact of low doses of the cancer drug nilotinib (Tasigna®). GUMC is conducting the study with its clinical partner, MedStar Georgetown University Hospital.The rationale for using nilotinib is based on laboratory and clinical research conducted by the Georgetown Translational Neurotherapeutics Program (TNP). Nilotinib appears to aid in the clearance of accumulated…

Read More

Transplant Patient Starts off New Year with a Better Night’s Sleep and Gratitude for NPR Listeners after National Broadcast

MedStar Georgetown kidney transplant recipient Constance Creasey learned about the kindness of strangers after a national radio broadcast featured her story, along with an interview with Dr. Matthew Cooper, MD, medical director of the Kidney Pancreas Transplant program at the MedStar Georgetown Transplant Institute.NPR national medical correspondent Richard Harris compiled a story about Medicare coverage of anti-rejection drugs that expires after three years, but continues to pay for dialysis and even a new transplant. Dr. Cooper commented that this is a policy he believes needs to change.To add patient perspective NPR interviewed Creasey, age 60 of Washington, D.C. who mentioned…

Read More

Top News
Tomorrow’s Cancer Treatments Today: Precision Medicine Intersects with Immunotherapy to Shrink Advanced Cancer in Maryland Woman
News
Tomorrow’s Cancer Treatments Today: Precision Medicine Intersects with Immunotherapy…
Close
What can we
Help you Find?

Begin your search for a physician, service or location.

Find a Doctor

Start looking for the right physician to meet your health needs.

Find a Doctor

Call Us Today

Schedule an appointment or get more information about our services.

855-MED-0364

Contact Us

For access to unsurpassed health care treatment, contact us now.

Contact Us